Get the latest tech news
If 23andMe Is Up for Sale, So Is All That DNA
23andMe is not doing well. Its stock is on the verge of being delisted. It shut down its in-house drug-development unit last month, only the latest in several rounds of layoffs. Last week, the entire board of directors quit, save for Anne Wojcicki, a co-founder and the company's CEO. Amid this downw...
Last week, the entire board of directors quit, save for Anne Wojcicki, a co-founder and the company's CEO. Amid this downward spiral, Wojcicki has said she'll consider selling 23andMe -- which means the DNA of 23andMe's 15 million customers would be up for sale, too. For about two decades now, since human-genome analysis became quick and common, the A's, C's, G's, and T's of DNA have allowed long-lost relatives to connect, revealed family secrets, and helped police catch serial killers.
Or read this on Slashdot